|
|
Perspective |
Immune ablation and stem cell transplantation for severe Evans syndrome and refractory thrombocytopenic purpura |
1215 |
AM Marmont
|
Full Article (PDF)
|
|
Conditioning Regimens |
Addition of high-dose Ara-C to the BMT conditioning regimen reduces leukemia relapse without an increase in toxicity |
1217 |
S Mineishi,
WL Longo,
ME Atkinson,
EP Smith,
M Hamielec,
SR Wiersma,
TJ Kinsella & FG Schuening
|
Abstract
Full Article (PDF)
|
|
Progenitor Cell Mobilisation |
Successful peripheral blood stem cell mobilization with etoposide (VP-16) in patients with relapsed or resistant lymphoma who failed cyclophosphamide mobilization |
1223 |
M Reiser,
A Josting,
A Draube,
MY Mapara,
C Scheid,
J Chemnitz,
H Tesch,
J Wolf,
V Diehl,
D Söhngen & A Engert
|
Abstract
Full Article (PDF)
|
|
Peripheral Blood Stem Cells |
Monitoring of CD34+ cells during leukapheresis allows a single, successful collection of hemopoietic progenitors in patients with low numbers of circulating stem cells |
1229 |
P de Fabritiis,
M Gonzalez,
G Meloni,
MS De Propris,
R Bellucci,
I Cordone,
M Gozzer,
G Leone & F Mandelli
|
Abstract
Full Article (PDF)
|
|
Factors predicting engraftment of autologous blood stem cells: CD34+ subsets inferior to the total CD34+ cell dose |
1237 |
DA Stewart,
D Guo,
J Luider,
I Auer,
J Klassen,
E Ching,
D Morris,
A Chaudhry,
C Brown & JA Russell
|
Abstract
Full Article (PDF)
|
|
Cytokines And Growth Factors |
Optimal timing of G-CSF administration after CD34+immunoselected peripheral blood progenitor cell transplantation |
1245 |
N Piccirillo,
S Sica,
L Laurenti,
P Chiusolo,
EO La Barbera,
F Sorà & G Leone
|
Abstract
Full Article (PDF)
|
|
Hematopoietic growth factor after autologous peripheral blood transplantation: comparison of G-CSF and GM-CSF |
1251 |
J Jansen,
EM Thompson,
S Hanks,
AR Greenspan,
JM Thompson,
MJ Dugan & LP Akard
|
Abstract
Full Article (PDF)
|
|
Acute Leukaemia |
Allogeneic bone marrow transplantation vs chemotherapy for the treatment of childhood acute lymphoblastic leukaemia in second complete remission (revisited 10 years on) |
1257 |
A Torres,
MA Alvarez,
J Sánchez,
R Flores,
F Martinez,
P Gómez,
R Rojas,
C Herrera,
JM García,
P Andrés,
F Velasco,
J Serrano,
J Román,
A Rodriguez,
C Martin,
S Tabares,
JM Rodriguez,
R Parody,
E Plaza,
A León,
R Romero,
E Jean-Paul,
D Prados,
R Aljama & A Fernández
|
Abstract
Full Article (PDF)
|
|
Myeloma |
Beta2-microglobulin and bone marrow plasma cell involvement predict complete responders among patients undergoing blood cell transplantation for myeloma |
1261 |
SV Rajkumar,
R Fonseca,
MQ Lacy,
TE Witzig,
JA Lust,
PR Greipp,
TM Therneau,
RA Kyle,
MR Litzow & MA Gertz
|
Abstract
Full Article (PDF)
|
|
Autologous stem cell transplantation for relapsed and primary refractory myeloma |
1267 |
SV Rajkumar,
R Fonseca,
MQ Lacy,
TE Witzig,
JA Lust,
PR Greipp,
TM Therneau,
RA Kyle,
MR Litzow & MA Gertz
|
Abstract
Full Article (PDF)
|
|
Autografting |
Analysis of feasibility of myeloablative therapy and autologous peripheral stem cell (PBSC) transplantation in the elderly: an interim report |
1273 |
P Mazza,
G Palazzo,
B Amurri,
M Cervellera,
N Manna,
G Fellini,
F Casulli,
M Ghiggini,
A Peluso,
G Pricolo,
A Prudenzano & L Stani
|
Abstract
Full Article (PDF)
|
|
Peripheral blood stem cell transplantation as an alternative to autologous marrow transplantation in the treatment of acute myeloid leukemia? |
1279 |
E Vellenga,
WLJ van Putten,
MA Boogaerts,
SMGJ Daenen,
GEG Verhoef,
A Hagenbeek,
AR Jonkhoff,
PC Huijgens,
LF Verdonck,
J van der Lelie,
HC Schouten,
J Gmür,
P Wijermans,
A Gratwohl,
U Hess,
MF Fey & B Löwenberg
|
Abstract
Full Article (PDF)
|
|
Graft-Versus-Host Disease |
A metalloproteinase inhibitor prevents acute graft-versus-host disease in mice after bone marrow transplantation |
1283 |
K Hattori,
T Hirano,
C Ushiyama,
H Miyajima,
N Yamakawa,
S Ikeda,
K Yoshino,
M Tateno,
K Oshimi,
N Kayagaki,
H Yagita & K Okumura
|
Abstract
Full Article (PDF)
|
|
Tacrolimus for prevention of graft-versus-host disease after mismatched unrelated donor cord blood transplantation |
1291 |
D Przepiorka,
D Petropoulos,
CA Mullen,
M Danielson,
V Mattewada & K-W Chan
|
Abstract
Full Article (PDF)
|
|
Tumour Cell Contamination |
Immunohistochemical detection of breast cancer cells in paired peripheral blood progenitor cell specimens collected after cytokine or cytokine and myelosuppressive chemotherapy |
1297 |
MB Kleinman,
EL Wiley,
M Guo,
AW Rademaker,
M Villa,
MS Tallman,
SB Newman,
LI Gordon & JN Winter
|
Abstract
Full Article (PDF)
|
|
Purging |
Clinical use of streptolysin-O to facilitate antisense oligodeoxyribonucleotide delivery for purging autografts in chronic myeloid leukaemia |
1303 |
RE Clark,
J Grzybowski,
CM Broughton,
NT Pender,
DG Spiller,
CG Brammer,
RV Giles & DM Tidd
|
Abstract
Full Article (PDF)
|
|
Miscellaneous Complications |
Toxicities after peripheral blood progenitor cell transplantation for lymphoid malignancies: analysis of 300 cases in a single institution |
1309 |
N Ketterer,
A Sonet,
C Dumontet,
I Moullet,
C Thieblemont,
D Espinouse,
F Bouafia,
B Coiffier & G Salles
|
Abstract
Full Article (PDF)
|
|
Infections Post Transplant |
Herpes zoster ophthalmicus following bone marrow transplantation in children |
1317 |
RC Walton & KL Reed
|
Abstract
Full Article (PDF)
|
|
Case Reports |
Successful treatment of advanced natural killer cell lymphoma with high-dose chemotherapy and syngeneic peripheral blood stem cell transplantation |
1321 |
Y Nawa,
K Takenaka,
K Shinagawa,
S Deguchi,
N Matsumura,
S Koyama,
Y Hiramatsu,
E Omoto,
T Yoshino & M Harada
|
Abstract
Full Article (PDF)
|
|
Post-mortem incidental finding of cytomegalovirus oophoritis after an allogeneic stem cell transplant |
1323 |
Y Nieto,
M Ross,
R Gianani,
EJ Shpall,
PJ Cagnoni,
SI Bearman & RB Jones
|
Abstract
Full Article (PDF)
|
|
Correspondence |
Adverse drug reactions associated with the administration of amphotericin B lipid complex (Abelcet) |
1325 |
G Cook & IM Franklin
|
Full Article (PDF)
|
|
Erratum |
Case Report: Acute graft-versus-host disease after bone marrow transplantation with a single HLA-DPB1*1001 mismatch: involvement of different TCRBV subsets |
1327 |
J Gaschet,
G Gallot,
C Ibisch,
A Lim,
J Even,
R Vivien,
MM Hallet,
N Milpied & H Vié
|
Full Article (PDF)
|
|
Author Index |
Author index to Volume 23 |
1329 |
|
Full Article (PDF)
|
|
Keyword Index |
Keyword index to Volume 23 |
1337 |
|
Full Article (PDF)
|
|